{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:02:03Z","timestamp":1787169723736,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cholinergic itch is part of symptom complex that also includes cholinergic erythema and cholinergic urticaria. It mostly occurs during the winters among young adults. It is characterized by onset of severe itching or burning sensation all over body, mostly, on exposure to sunlight, warm atmosphere and in some cases after hot and spicy food intake. In most of the cases, it is poorly responsive to antihistamine therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>This was a prospective, open labeled, clinical study done in patients of cholinergic itch, refractory to both sedating and non sedating anti-histamine drugs, who attended dermatology clinic of our tertiary care center from November, 2020 to February, 2021. Oral cyclosporine was given as treatment. Numerical rating scale (NRS) was used to record the treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty patients with cholinergic itch meeting inclusion criteria were included in the study. Mean age of disease onset was 19.5 years. Average duration of each episode was 4.4-8 minutes. More than one site was involved in all patients with trunk being the commonest (100%). There was significant reduction in the number of episodes and cholinergic itch severity (mean NRS=7.8 to 0.3 at the end of second week after initiating cyclosporine therapy). P value of the study was &lt;0.0001.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistics:<\/jats:title>\n                    <jats:p>Mean and standard deviation were used as measure of central tendency. Paired t test was applied to analyze the data obtained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Oral cyclosporine effectively controlled cholinergic itch in all included patients. Drug was well tolerated by the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_584_21","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:02:05Z","timestamp":1646265725000},"page":"234-236","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Cyclosporine in Cholinergic Itch"],"prefix":"10.4103","volume":"13","author":[{"given":"Sumit","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanshika","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Khare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240828","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archderm.1944.01510160019009","article-title":"Cholinergic urticaria and cholinergic itching","volume":"50","author":"Nomland","year":"1944","journal-title":"Arch Derm Syph"},{"key":"R2-9-20240828","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2133.1989.tb01804.x","article-title":"Cholinergic pruritus, erythema and urticaria: A disease spectrum responding to danazol","volume":"121","author":"Berth-Jones","year":"1989","journal-title":"Br J Dermatol"},{"key":"R3-9-20240828","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2019.06.043","article-title":"Validity and reliability of itch assessment scales for chronic pruritus in adults: A prospective multicenter study","volume":"82","author":"Jang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R4-9-20240828","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10286-017-0418-6","article-title":"Cholinergic urticaria: Epidemiology, physiopathology, new categorization, and management","volume":"28","author":"Fukunaga","year":"2018","journal-title":"Clin Auton Res"},{"key":"R5-9-20240828","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/ced.14052","article-title":"Cholinergic pruritus responding to omalizumab","volume":"45","author":"Hasan","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"R6-9-20240828","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1254\/jjp.88.351","article-title":"Intradermal cholinergic agonists induce itch-associated response via M3 muscarinic acetylcholine receptors in mice","volume":"88","author":"Miyamoto","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"R7-9-20240828","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archderm.1988.01670010048020","article-title":"Aquagenic pruritus.Water-induced activation of acetylcholinesterase","volume":"124","author":"Bircher","year":"1988","journal-title":"Arch Dermatol"},{"key":"R8-9-20240828","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.alit.2020.05.006","article-title":"Direct and indirect action modes of acetylcholine in cholinergic urticaria","volume":"70","author":"Tokura","year":"2021","journal-title":"Allergol Int"},{"key":"R9-9-20240828","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000057877","article-title":"Cholinergic urticaria, a new pathogenic concept: Hypohidrosis due to interference with the delivery of sweat to the skin surface","volume":"204","author":"Kobayashi","year":"2002","journal-title":"Dermatology"},{"key":"R10-9-20240828","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000247748","article-title":"Sweat-related dermatoses: Old concept and new scenario","volume":"182","author":"Hu","year":"1991","journal-title":"Dermatologica"},{"key":"R11-9-20240828","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jlb.57.3.434","article-title":"Normal human sweat contains interleukin-8","volume":"57","author":"Jones","year":"1995","journal-title":"J Leukoc Biol"},{"key":"R12-9-20240828","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2230.1996.tb00120.x","article-title":"The sweat of patients with atopic dermatitis contains specific IgE antibodies to inhalant allergens","volume":"21","author":"Jung","year":"1996","journal-title":"J Clin Exp Dermatol"},{"key":"R13-9-20240828","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/000155502320624050","article-title":"IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis","volume":"82","author":"Hide","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"R14-9-20240828","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1398-9995.2010.01995.x","article-title":"Pathophysiology and therapy of pruritus in allergic and atopic diseases","volume":"65","author":"Buddenkotte","year":"2010","journal-title":"Allergy"},{"key":"R15-9-20240828","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s13555-019-00321-6","article-title":"The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo","volume":"9","author":"Zeidler","year":"2019","journal-title":"Dermatol Ther (Heidelb"},{"key":"R16-9-20240828","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2340\/0001555570323329","article-title":"Antipruritic effect of oral cyclosporine A in atopic dermatitis","volume":"70","author":"Wahlgren","year":"1990","journal-title":"Acta Derm Venereol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_584_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:09Z","timestamp":1787166669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_584_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_584_21","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}